You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era

Article metrics

Article menu

Download PDFPDF

XML
Review
Treatment choices for diabetic macular oedema: a guideline for when to consider an intravitreal corticosteroid, including adaptations for the COVID-19 era

 

Online download statistics by month:

Online download statistics by month: April 2021 to March 2024

AbstractFullPdf
Apr 2021646420
May 2021325326558
Jun 202116115957
Jul 202125826072
Aug 2021279276112
Sep 202125225385
Oct 2021339344111
Nov 2021317306112
Dec 202130831084
Jan 2022306309110
Feb 202235535792
Mar 2022364372117
Apr 2022288291101
May 2022387398116
Jun 2022377385106
Jul 2022250237197
Aug 2022295298410
Sep 2022311313362
Oct 2022297302344
Nov 2022327322204
Dec 202225725487
Jan 2023250252202
Feb 2023227229144
Mar 2023227232202
Apr 2023198199113
May 2023266271110
Jun 2023253260125
Jul 202325125667
Aug 202327127593
Sep 202322522986
Oct 2023285289107
Nov 202329229797
Dec 202317617856
Jan 202411411741
Feb 202420621180
Mar 202447047867
Total982899095047